Prelude Capital Management, LLC Ars Pharmaceuticals, Inc. Comm Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
N/A
-1,436 Reduced 8.71%
15,053 $0
Q4 2022

Feb 14, 2023
SELL
N/A
-3,205 Reduced 16.27%
16,489 $0
Q3 2022

Nov 14, 2022
SELL
N/A
-22,006 Reduced 52.77%
19,694 $104,000
Q2 2022

Aug 15, 2022
BUY
N/A
7,700 Added 22.65%
41,700 $177,000
Q1 2022

May 16, 2022
BUY
N/A
17,300 Added 103.59%
34,000 $119,000
Q4 2021

Feb 14, 2022
BUY
N/A
16,700 New
16,700 $111,000

About ARS PHARMACEUTICALS, INC. COMM

SPRY Quotes by TradingView
  • Ticker SPRY
More about SPRY
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email